CXCL10 and Alzheimer disease: Interestingly, a previous study on age-matched control and patient groups with an average age of 62 years showed increased levels of MCP-1 and IL-8 in AD patients whereas only a subset of the studied AD patients exhibited increased levels of IP-10, compared to controls [29].